REPLIMUNE GROUP, INC. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2024-02-08: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2023-11-07: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2023-08-03: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2023-05-18: Form 10-K; Item Emerging growth company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2024-02-08 | 10-Q | Emerging growth company | Yes |
| 2023-11-07 | 10-Q | Emerging growth company | Yes |
| 2023-08-03 | 10-Q | Emerging growth company | Yes |
| 2023-05-18 | 10-K | Emerging growth company | Yes |
| 2023-02-09 | 10-Q | Emerging growth company | Yes |
| 2022-11-03 | 10-Q | Emerging growth company | Yes |
| 2022-08-04 | 10-Q | Emerging growth company | Yes |
| 2022-05-19 | 10-K | Emerging growth company | Yes |
| 2022-02-03 | 10-Q | Emerging growth company | Yes |
| 2021-11-04 | 10-Q | Emerging growth company | Yes |
| 2021-08-06 | 10-Q | Emerging growth company | Yes |
| 2021-05-20 | 10-K | Emerging growth company | Yes |
| 2021-02-04 | 10-Q | Emerging growth company | Yes |
| 2020-11-05 | 10-Q | Emerging growth company | Yes |
| 2020-08-07 | 10-Q | Emerging growth company | Yes |
| 2020-06-03 | 10-K | Emerging growth company | Yes |
| 2020-02-13 | 10-Q | Smaller reporting company | No |
| 2020-02-13 | 10-Q | Emerging growth company | Yes |
| 2019-11-12 | 10-Q | Smaller reporting company | No |
| 2019-11-12 | 10-Q | Emerging growth company | Yes |
| 2019-08-14 | 10-Q | Smaller reporting company | No |
| 2019-08-14 | 10-Q | Emerging growth company | Yes |
| 2019-08-14 | 10-Q | Current in its reporting | No |
| 2019-06-28 | 10-K | Smaller reporting company | No |
| 2019-06-28 | 10-K | Emerging growth company | Yes |
| 2019-02-14 | 10-Q | Smaller reporting company | No |
| 2019-02-14 | 10-Q | Emerging growth company | Yes |
| 2018-11-14 | 10-Q | Smaller reporting company | No |
| 2018-11-14 | 10-Q | Emerging growth company | Yes |
| 2018-11-14 | 10-Q | Current in its reporting | No |
| 2018-08-30 | 10-Q | Current in its reporting | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |